Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuntai Zhou

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
ACS Infectious Diseases|November 3, 2022
Unique Molecular Identifiers and Multiplexing Amplicons Maximize the Utility of Deep Sequencing To Critically Assess Population Diversity in RNA VirusesShuntai Zhou, Collin S Hill, Ean Spielvogel, et al.
Bio-Protocol|April 2, 2021
Primer ID Next-Generation Sequencing for the Analysis of a Broad Spectrum Antiviral Induced Transition Mutations and Errors Rates in a Coronavirus GenomeShuntai Zhou, Collin S Hill, Michael U Clark, et al.
Journal of Virology|August 16, 2020
Two Genetic Differences between Closely Related Zika Virus Strains Determine Pathogenic Outcome in MiceDerek L Carbaugh, Shuntai Zhou, Wes Sanders, et al.
The Journal of Infectious Diseases|May 2, 2016
Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment DiscontinuationMaria M Bednar, Blake M Hauser, Shuntai Zhou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 25, 2009
Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009Shuntai Zhou, Yan Zhao, Yun He, et al.
AIDS Research and Human Retroviruses|March 10, 2015
Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding DomainJessica R Keys, Shuntai Zhou, Jeffrey A Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 30, 2016
Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID in a Viral Outgrowth AssaySook-Kyung Lee, Shuntai Zhou, Pedro L Baldoni, et al.
Open Forum Infectious Diseases|January 5, 2026
Neurosymptomatic Cerebrospinal Fluid Escape Is a Central Nervous System-Focused Form of Antiretroviral Therapy Treatment FailureLaura P Kincer, Ameet Dravid, Shuntai Zhou, et al.
SN Comprehensive Clinical Medicine|August 31, 2022
COVID-19 Outcomes in Stage IV Cancer Patients Receiving Immune Checkpoint InhibitorsMengni Guo, Jieying Liu, Shuntai Zhou, et al.
The Lancet. Infectious Diseases|May 24, 2011
Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort studyFujie Zhang, Zhihui Dou, Ye Ma, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
ACS Infectious Diseases|November 3, 2022
Unique Molecular Identifiers and Multiplexing Amplicons Maximize the Utility of Deep Sequencing To Critically Assess Population Diversity in RNA VirusesShuntai Zhou, Collin S Hill, Ean Spielvogel, et al.
Bio-Protocol|April 2, 2021
Primer ID Next-Generation Sequencing for the Analysis of a Broad Spectrum Antiviral Induced Transition Mutations and Errors Rates in a Coronavirus GenomeShuntai Zhou, Collin S Hill, Michael U Clark, et al.
Journal of Virology|August 16, 2020
Two Genetic Differences between Closely Related Zika Virus Strains Determine Pathogenic Outcome in MiceDerek L Carbaugh, Shuntai Zhou, Wes Sanders, et al.
The Journal of Infectious Diseases|May 2, 2016
Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment DiscontinuationMaria M Bednar, Blake M Hauser, Shuntai Zhou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 25, 2009
Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009Shuntai Zhou, Yan Zhao, Yun He, et al.
AIDS Research and Human Retroviruses|March 10, 2015
Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding DomainJessica R Keys, Shuntai Zhou, Jeffrey A Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 30, 2016
Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID in a Viral Outgrowth AssaySook-Kyung Lee, Shuntai Zhou, Pedro L Baldoni, et al.
Open Forum Infectious Diseases|January 5, 2026
Neurosymptomatic Cerebrospinal Fluid Escape Is a Central Nervous System-Focused Form of Antiretroviral Therapy Treatment FailureLaura P Kincer, Ameet Dravid, Shuntai Zhou, et al.
SN Comprehensive Clinical Medicine|August 31, 2022
COVID-19 Outcomes in Stage IV Cancer Patients Receiving Immune Checkpoint InhibitorsMengni Guo, Jieying Liu, Shuntai Zhou, et al.
The Lancet. Infectious Diseases|May 24, 2011
Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort studyFujie Zhang, Zhihui Dou, Ye Ma, et al.
Pageof 6